QA: Lixte Biotechnology Holdings INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2017_Lixte_Biotechnology_Holdings_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001335105, Lixte Biotechnology Holdings INC

  xvar xval
0 AssetsCurrent 433,411
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 218,651
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 799,144
9 ResearchAndDevelopmentExpense 1,504,406
10 remainder_Expenses 84,132
11 remainder_Revenues 0
12 remainder_NetIncome 199,539
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 433,411
1 Liabilities 218,651
2 Expenses 2,387,682
3 Revenues 0
4 StockholdersEquity 214,760
5 NetIncome -2,188,143
6 ComprehensiveNetIncome -2,188,143
7 BaseVar 1,619,642
8 EconomicCapitalRatiobeforeLimitedLiability -5.28
9 EconomicCapitalRatio 0.152

Edgar->Model Mapping

Feature Distribution

Change over Time